Cholesterol-lowering drug can overcome chemotherapy resistance in triple-negative breast cancer – BioNews Central Pitavastatin, a common cholesterol-lowering drug, counteracts chemotherapy resistance in triple-negative breast cancer cells by directly blocking the anti-apoptotic protein Mcl-1. ...

#Pitavastatin, a common #CholesterolLoweringDrug, counteracts #ChemotherapyResistance in #TripleNegativeBreastCancer cells by directly blocking the anti-apoptotic protein Mcl-1.
#Statins #BreastCancer #BreastCancerTreatment